Comments
Loading...
Natera (NASDAQ:NTRA) Stock Quotes, Forecast and News Summary
Natera Stock (NASDAQ: NTRA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Natera (NTRA) stock?
You can purchase shares of Natera (NASDAQ:NTRA) through any online brokerage.
Who are Natera (NTRA) competitors?
Other companies in Natera’s space includes: Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).
What is the forecast, or price target, for Natera (NTRA) stock?
Natera has a consensus price target of $142.94.
What is the current price for Natera (NTRA)?
The stock price for Natera (NASDAQ: NTRA) is $165.65 last updated December 18, 2024 at 1:05 PM EST.
Does Natera (NTRA) pay a dividend?
There are no upcoming dividends for Natera.
When is Natera (NASDAQ:NTRA) reporting earnings?
Natera’s Q4 earnings are confirmed for Wednesday, February 26, 2025.
Is Natera (NTRA) going to split?
There is no upcoming split for Natera.
What sector and industry does Natera (NTRA) operate in?
Natera is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.